Gongbo Fu

1.4k total citations · 1 hit paper
32 papers, 927 citations indexed

About

Gongbo Fu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Gongbo Fu has authored 32 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in Gongbo Fu's work include Liver physiology and pathology (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Gongbo Fu is often cited by papers focused on Liver physiology and pathology (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Gongbo Fu collaborates with scholars based in China and United States. Gongbo Fu's co-authors include He‐Xin Yan, Hongyang Wang, Min Zeng, Xu Zhou, Han Wu, Chenjie Qin, Hui‐Lu Zhang, Weijian Huang, Shuai Huang and Liang Tang and has published in prestigious journals such as Hepatology, Gut and Biochemical and Biophysical Research Communications.

In The Last Decade

Gongbo Fu

32 papers receiving 922 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity

2025 19 citations Xin Tao, Yiyang Xie et al. Cell Death Discovery profile →

Peers

Countries citing papers authored by Gongbo Fu

Since Specialization

Citations

This map shows the geographic impact of Gongbo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gongbo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gongbo Fu more than expected).

Fields of papers citing papers by Gongbo Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gongbo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gongbo Fu. The network helps show where Gongbo Fu may publish in the future.

Co-authorship network of co-authors of Gongbo Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Gongbo Fu. A scholar is included among the top collaborators of Gongbo Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gongbo Fu. Gongbo Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials 2024 ·Journal of Translational Medicine ·Wendi Jiang, (unknown), Qingquan Luo, (unknown), (unknown), Xin Tao, Yiyang Xie, (unknown), Longwei Jiang, (unknown), Gongbo Fu, Zengjie Lei	5
2	Survival analysis and prognostic model establishment of secondary osteosarcoma: a SEER-based study 2024 ·Annals of Medicine and Surgery ·Jing Wang, Gongbo Fu, (unknown), Lan Ding, Yitian Chen, (unknown), Dan Xiang, Z. G. Dai, (unknown), Linlin Ji, Zengjie Lei, Xiaoyuan Chu	1
3	CD24+LCN2+ liver progenitor cells in ductular reaction contributed to macrophage inflammatory responses in chronic liver injury 2023 ·Cell & Bioscience ·Weijian Huang, Bijun Qiu, (unknown), Cai–Yang Chen, Wenming Liu, (unknown), Min Ding, (unknown), Jie Zhao, Dan Tang, (unknown), Gongbo Fu, Zhenyu Wang, (unknown), (unknown), Hongping Wu, Xiaosong Chen, Weifeng Yu, He‐Xin Yan	6
4	Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer 2023 ·Cell Death Discovery ·Jialong Zhu, Linlin Ji, Yitian Chen, Huiyu Li, Mengxi Huang, (unknown), Jing Wang, Dan Xiang, Gongbo Fu, Zengjie Lei, Xiaoyuan Chu	47
5	Case report: POLE (P286R) mutation in a case of recurrent intestinal leakage and its treatment 2023 ·Frontiers in Oncology ·(unknown), Gongbo Fu, Yitian Chen, Xiaoyuan Chu	2
6	Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation 2022 ·Advanced Science ·Hui‐Lu Zhang, Ping Chen, He‐Xin Yan, Gongbo Fu, (unknown), Jun Zhang, Shi‐Min Zhao, Bo Zhai, Jianghong Yu, Lin Chen, (unknown), Jian Chen, Shuai Huang, Jun Zeng, Wei Xu, Hong‐Yang Wang, (unknown)	28
7	Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma 2022 ·Pharmacological Research ·Xiuliang Cui, Lu Han, (unknown), Gongbo Fu, Erdong Liu, Duowei Wang, Bin Song, Yongxiang Zhang, Wenxia Zhou, Hongyang Wang, Jing Fu	4
8	A narrative review of the roles of muscle segment homeobox transcription factor family in cancer 2021 ·Annals of Translational Medicine ·Chao Liu, Mengxi Huang, Chao Han, Huiyu Li, Jing Wang, Yadi Huang, Yanyan Chen, Jialong Zhu, Gongbo Fu, Hanqing Yu, Zengjie Lei, Xiaoyuan Chu	4
9	Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer 2021 ·Frontiers in Oncology ·(unknown), Mengxi Huang, Chenglong He, Cheng Chen, Huiyu Li, Jing Wang, (unknown), Gongbo Fu, Zengjie Lei, Xiaoyuan Chu	3
10	Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs 2021 ·Theranostics ·Jun Weng, (unknown), Fanhong Zeng, Yue Zhang, Lei Feng, Lei Cai, (unknown), (unknown), Li Shao, Gongbo Fu, Min Zeng, Yi Gao	16
11	An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs 2020 ·Science Translational Medicine ·Weijian Li, Xuejing Zhu, (unknown), Zhenyu Wang, (unknown), (unknown), (unknown), Cai–Yang Chen, Gongbo Fu, Weijian Huang, Yao Shi, Qian Liu, Min Zeng, (unknown), Hongping Wu, Weifeng Yu, Bo Zhai, He‐Xin Yan	31
12	Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance 2019 ·Gut ·Daimin Xiang, Wen Sun, Tengfei Zhou, Cheng Zhang, Zhuo Cheng, Shichao Li, (unknown), Ruoyu Wang, Gongbo Fu, Xiuliang Cui, Guojun Hou, Guang‐Zhi Jin, Hengyu Li, (unknown), Hui Liu, Hongyang Wang, Jin Ding	97
13	mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma 2019 ·Cell Death and Disease ·Ting Li, Jun Weng, Yue Zhang, (unknown), Gongbo Fu, (unknown), Xiaochun Bai, Yi Gao	34
14	Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening 2019 ·Theranostics ·Zhenyu Wang, Weijian Li, (unknown), (unknown), Gongbo Fu, (unknown), Weijian Huang, (unknown), Dan Tang, Min Zeng, Yi Chen, Hongdan Zhang, Xuejing Zhu, Yuan Peng, Qigen Li, Weifeng Yu, He‐Xin Yan, Bo Zhai	35
15	A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro 2019 ·Biomedicine & Pharmacotherapy ·Zhenyu Wang, Weijian Li, Qigen Li, (unknown), (unknown), Gongbo Fu, Dan Tang, (unknown), He‐Xin Yan, Bo Zhai	16
16	Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens 2018 ·Cell Research ·Gongbo Fu, Weijian Huang, Min Zeng, Xu Zhou, Hongping Wu, Changcheng Liu, Han Wu, Jun Weng, (unknown), Yongchao Cai, Charles Ashton, Min Ding, Dan Tang, Baohua Zhang, Yi Gao, Weifeng Yu, Bo Zhai, Zhiying He, Hongyang Wang, He‐Xin Yan	117
17	Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2 2018 ·Cancer Letters ·Chenjie Qin, Linghao Zhao, Xu Zhou, Hui‐Lu Zhang, Wen Wen, Liang Tang, Min Zeng, Ming-Da Wang, Gongbo Fu, Shuai Huang, Weijian Huang, Yuan Yang, Zhijun Bao, Weiping Zhou, Hongyang Wang, He‐Xin Yan	48
18	Maintaining viability and characteristics of cholangiocarcinoma tissue by vitrification-based cryopreservation 2017 ·Cryobiology ·Min Zeng, (unknown), Gongbo Fu, Yuan Zhang, Xu Zhou, Weijian Huang, (unknown), Weijian Li, Zhenyu Wang, He‐Xin Yan, Bo Zhai	5
19	Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis 2017 ·Science China Life Sciences ·Chenjie Qin, (unknown), Linghao Zhao, Min Zeng, Weijian Huang, Gongbo Fu, Weiping Zhou, Hongyang Wang, He‐Xin Yan	16
20	Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment 2016 ·Cancer Letters ·Hui‐Lu Zhang, Ming-Da Wang, Xu Zhou, Chenjie Qin, Gongbo Fu, Liang Tang, Han Wu, Shuai Huang, Linghao Zhao, Min Zeng, Jiao Liu, Dan Cao, Linna Guo, Hongyang Wang, He‐Xin Yan, Jie Liu	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact